MEDICINOVA, INC. Current Portion of Long-Term Debt
MEDICINOVA, INC. (MNOV) had Current Portion of Long-Term Debt of $0 as of 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:LongTermDebtCurrent · last filed 2012-03-29
- 2011-09-30: Long-term Debt, Current Maturities $0.00.
- 2011-06-30: Long-term Debt, Current Maturities $0.00.
- 2010-12-31: Long-term Debt, Current Maturities $4.95M.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 |
| 2010-12-31 | $4.95M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |